NZ sharemarket starts week down 0.5%

NZ sharemarket starts week down 0.5%
(Image: Getty)
Graham Skellern
Cancer diagnostic company Pacific Edge slumped 55% after failing to get the backing for continued United States Medicare payments for its Cxbladder tests, and the New Zealand sharemarket joined global moves with a fall.After a sell-down on Wall Street at the weekend, the S&P/NZX 50 Index traded weakly till a late turnaround and closed at 12,827.33, down 68.65 points or 0.53%. Volumes were light, with 30.08 million shares worth $71.1 million changing hands – nearly half of them being Pacific Edge on trade of 13.12 million shares w...

More Markets

Employment data dominates quiet day on NZ sharemarket
Markets

Employment data dominates quiet day on NZ sharemarket

The NZ sharemarket was down with no real trend driving the change.

Sharesies founders sell down
Markets

Sharesies founders sell down

Global tech investor Rahul Mehta appears in Companies Office filings for the first time.

Fletcher’s home consenting has tanked: Macquarie
Property

Fletcher’s home consenting has tanked: Macquarie

Building giant’s land sell-off may deepen residential gloom, analysts say.